Download Files:
Vutrisiran
$1,450 – $5,150
Products Details
Product Description
– Vutrisiran (ALN-TTRsc02) is a liver-directed, investigational, small interfering ribonucleic acid (siRNA) agent. Vutrisiran can be used for transthyretin (TTR)-mediated amyloidosis research[1].
Web ID
– HY-132589
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture)
Shipping
– Room Temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C530H715F9N171O323P43S6
References
– [1]Bahru A Habtemariam, et al. Single-Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N-acetylgalactosamine-Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects. Clin Pharmacol Ther. 2021 Feb;109(2):372-382.
CAS Number
– 1867157-35-4
Molecular Weight
– 16345 (AS: 7556.3; SS: 8788.7 )
Compound Purity
– 96.37
SMILES
– [Vutrisiran]
Clinical Information
– Launched
Research Area
– Neurological Disease
Solubility
– H2O : ≥ 20 mg/mL
Target
– Small Interfering RNA (siRNA);Transthyretin (TTR)
Pathway
– Epigenetics;Neuronal Signaling
Product type
– Oligonucleotides
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
